Our Pricing

What You Need to Know About Mounjaro in Fareham

Published: 3 October 2026

If you're searching for Mounjaro Fareham, you're likely exploring prescription weight loss options available through UK-registered online pharmacies serving the Hampshire area. Mounjaro (tirzepatide) is a once-weekly injection licensed by the MHRA for weight management in adults with a BMI ≥30 or ≥27 with weight-related conditions, and it's available from Cured Pharmacy from £124.99 following a free online clinical assessment by our UK prescribers. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription is dispensed safely, with discreet delivery direct to your Fareham address.

How to Access Mounjaro Fareham Through Cured Pharmacy

Accessing Mounjaro Fareham is straightforward with Cured Pharmacy's fully regulated online service. Unlike traditional high-street pharmacies, our digital consultation process takes under three minutes and connects you directly with UK-registered prescribers who assess your suitability based on NICE guidelines for weight management medications [1]. You'll complete a confidential medical questionnaire covering your weight history, current medications, and any contraindications specific to tirzepatide.

Once your clinical assessment is approved, your prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in 100% discreet packaging to your Fareham address, typically arriving within 2-3 working days. All Mounjaro supplied by Cured Pharmacy is genuine, UK-licensed medication sourced through regulated wholesalers, ensuring you receive the same pharmaceutical-grade tirzepatide approved for use across the NHS and private sector. Our transparent pricing model shows you the exact cost—from £124.99—before you begin your consultation, with no hidden fees.

Mounjaro Fareham Pricing and Discount Codes

Cured Pharmacy offers Mounjaro Fareham at competitive UK pricing starting from £124.99, with an additional £20 off your first order when you use code Weightlossnew at checkout. This pricing structure reflects our commitment to making clinically proven weight loss treatments accessible to patients across Hampshire without compromising on quality or regulatory compliance.

The cost of Mounjaro varies depending on your prescribed dosage strength (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg), with most patients starting on the 2.5mg maintenance dose and titrating upwards as directed by their prescriber. Our pricing remains transparent throughout your treatment journey, and we never charge consultation fees—your assessment is completely free, and you only pay for the medication if deemed clinically appropriate by our prescribers.

Understanding Mounjaro Dosage Costs in Fareham

Each Mounjaro KwikPen contains four doses for once-weekly administration, meaning a single pen lasts one month when used as prescribed. The SURPASS clinical trial programme demonstrated that tirzepatide achieved average weight reductions of 15-22.5% of initial body weight over 72 weeks, depending on the final maintenance dose [2]. Your prescriber will adjust your dosage based on tolerance and weight loss progress, with most patients reaching therapeutic doses (10mg-15mg) within 16-20 weeks of treatment initiation.

Clinical Effectiveness of Mounjaro for Fareham Patients

Mounjaro Fareham patients can expect clinically significant weight loss outcomes based on extensive trial data from the SURPASS and SURMOUNT programmes. In the SURMOUNT-1 trial, participants without type 2 diabetes achieved average weight reductions of 15.0% (5mg dose), 19.5% (10mg dose), and 20.9% (15mg dose) over 72 weeks, compared to 3.1% with placebo [3]. These results represent some of the most substantial weight loss outcomes observed in any pharmaceutical intervention to date.

Tirzepatide works through dual agonism of GIP and GLP-1 receptors, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite through central nervous system pathways [4]. This dual mechanism distinguishes Mounjaro from single-incretin therapies like semaglutide, potentially explaining its superior efficacy in head-to-head trials. Patients in Fareham using Mounjaro through Cured Pharmacy receive ongoing support and monitoring to optimise outcomes while managing potential side effects such as nausea, diarrhoea, and constipation, which typically diminish after the initial titration period.

Who Can Use Mounjaro in Fareham

Mounjaro Fareham prescriptions are issued in accordance with MHRA licensing and NICE guidance, which stipulate eligibility for adults with a BMI ≥30 kg/m² or ≥27 kg/m² in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea [1]. Our prescribers assess each patient individually, considering contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and pregnancy or breastfeeding.

Mounjaro Fareham Delivery and Packaging Options

When you order Mounjaro Fareham through Cured Pharmacy, your medication arrives in completely discreet packaging with no external branding or indication of contents. We understand that privacy matters, particularly for weight management treatments, so every parcel is designed to protect your confidentiality from dispatch to doorstep delivery in Fareham and surrounding Hampshire postcodes.

All Mounjaro shipments are sent via tracked courier services, allowing you to monitor your delivery in real-time and plan to receive your temperature-sensitive medication safely. Tirzepatide requires refrigeration between 2-8°C, so we include cold-chain packaging to maintain stability during transit. Once received, store your Mounjaro pens in the refrigerator and never freeze them—frozen tirzepatide must be discarded as the protein structure degrades irreversibly.

Comparing Mounjaro Fareham to Other Weight Loss Treatments

Patients exploring Mounjaro Fareham often compare it to alternative weight loss medications available through Cured Pharmacy, including Wegovy (semaglutide), Saxenda (liraglutide), and oral options like Orlistat. While all these treatments are MHRA-licensed for weight management, they differ significantly in mechanism, efficacy, administration route, and side effect profiles.

Head-to-head trials such as SURPASS-2 demonstrated that tirzepatide (Mounjaro) achieved superior weight loss compared to semaglutide 1mg in patients with type 2 diabetes, with the 15mg tirzepatide dose producing 5.5kg greater average weight reduction than semaglutide over 40 weeks [5]. For patients without diabetes, the SURMOUNT trials showed average weight losses exceeding 20% with higher Mounjaro doses, substantially greater than the 15% average observed with Wegovy 2.4mg in the STEP trials [3][6]. Our clinical team can help Fareham patients determine which treatment aligns best with their medical history, weight loss goals, and tolerance for injection-based therapy.

Oral vs Injectable Weight Loss Options in Fareham

Some Fareham patients prefer oral medications to avoid injections, making Wegovy Oral Tablets (semaglutide pill) or Orlistat viable alternatives to Mounjaro. Wegovy Oral Tablets from £20 offer the convenience of daily pill administration while delivering semaglutide's proven weight loss benefits, though clinical data suggests injectable formulations may achieve slightly greater efficacy due to superior bioavailability. Orlistat, available from £124.99, works through a completely different mechanism—blocking fat absorption in the gut—and produces more modest weight loss (typically 5-10% of body weight) but requires no injection and has decades of safety data supporting its use.

Starting Your Mounjaro Fareham Treatment Safely

Beginning Mounjaro Fareham treatment requires careful medical oversight to optimise safety and efficacy. All patients start on the 2.5mg dose for the first four weeks, allowing your body to adjust to tirzepatide's effects on gastric emptying and appetite regulation. This gradual titration schedule, validated in the SURPASS trials, minimises gastrointestinal side effects while building therapeutic drug levels [2].

After the initial month, your prescriber will typically increase your dose to 5mg, then continue escalating by 2.5mg increments every four weeks until you reach your target maintenance dose or experience dose-limiting side effects. Most Fareham patients achieve optimal results on 10mg, 12.5mg, or 15mg weekly doses, though some maintain excellent weight loss on lower strengths. Our clinical team provides ongoing support throughout your treatment journey, with regular check-ins to monitor progress, adjust dosing, and address any concerns about side effects or weight loss plateaus. Remember that Mounjaro works best when combined with a reduced-calorie diet and increased physical activity, as demonstrated in all major clinical trials where lifestyle interventions were implemented alongside pharmacotherapy [3][7].

Managing Mounjaro Side Effects in Fareham

The most common side effects reported by Mounjaro Fareham users include nausea (affecting up to 30% of patients), diarrhoea, decreased appetite, vomiting, constipation, and abdominal discomfort [8]. These gastrointestinal symptoms typically peak during the first few weeks after each dose escalation and diminish as your body adapts. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can significantly reduce symptom severity. If side effects become intolerable, your prescriber may slow the titration schedule or maintain you on a lower dose for an extended period before attempting further increases.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 3 October 2026]
2. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 3 October 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 3 October 2026]
4. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 3 October 2026]
5. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10296), 64-77. [accessed 3 October 2026]
6. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 3 October 2026]
7. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 3 October 2026]
8. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. MHRA. [accessed 3 October 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 3 October 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 3 October 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 3 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.